TN2009000197A1 - Sustained - release composition and method for producing the same - Google Patents

Sustained - release composition and method for producing the same

Info

Publication number: TN2009000197A1
Authority: TN; Tunisia
Prior art keywords: sustained; physiologically active; producing; same; release
Prior art date: 2006-12-18

Application number

TNP2009000197A

Other languages

English (en)

Inventor

Tomomichi Futo

Kazuhiro Saito

Tetsuo Hoshino

Masuhisa Hori

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-18

Filing date

2009-05-20

Publication date

2010-10-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39015849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TN2009000197(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-05-20 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2010-10-18 Publication of TN2009000197A1 publication Critical patent/TN2009000197A1/fr

Links

238000013268 sustained release Methods 0.000 title abstract 3
239000012730 sustained-release form Substances 0.000 title abstract 3
238000004519 manufacturing process Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 4
239000013543 active substance Substances 0.000 abstract 2
235000014655 lactic acid Nutrition 0.000 abstract 2
239000004310 lactic acid Substances 0.000 abstract 2
239000003094 microcapsule Substances 0.000 abstract 2
229920000642 polymer Polymers 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
230000001629 suppression Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Reproductive Health (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Pregnancy & Childbirth (AREA)
Nanotechnology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Manufacturing Of Micro-Capsules (AREA)

TNP2009000197A 2006-12-18 2009-05-20 Sustained - release composition and method for producing the same TN2009000197A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US87536406P	2006-12-18	2006-12-18
US91740107P	2007-05-11	2007-05-11
PCT/JP2007/074617 WO2008075762A1 (fr)	2006-12-18	2007-12-17	Composition à libération prolongée et procédé de production correspondant

Publications (1)

Publication Number	Publication Date
TN2009000197A1 true TN2009000197A1 (en)	2010-10-18

Family

ID=39015849

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TNP2009000197A TN2009000197A1 (en)	2006-12-18	2009-05-20	Sustained - release composition and method for producing the same

Country Status (27)

Country	Link
US (3)	US8921326B2 (fr)
EP (1)	EP2094246B1 (fr)
JP (2)	JP4564098B2 (fr)
KR (1)	KR101522035B1 (fr)
CN (1)	CN101563068B (fr)
AR (1)	AR064381A1 (fr)
AU (1)	AU2007335406B2 (fr)
BR (1)	BRPI0720582B1 (fr)
CA (1)	CA2671670C (fr)
CL (1)	CL2007003658A1 (fr)
CO (1)	CO6180498A2 (fr)
CR (1)	CR10867A (fr)
DO (1)	DOP2009000144A (fr)
EA (1)	EA016176B1 (fr)
EC (1)	ECSP099439A (fr)
ES (1)	ES2791698T3 (fr)
GE (1)	GEP20125597B (fr)
IL (1)	IL198845A (fr)
MA (1)	MA31006B1 (fr)
MX (1)	MX2009006653A (fr)
MY (1)	MY148370A (fr)
NO (1)	NO347209B1 (fr)
NZ (1)	NZ577281A (fr)
PE (1)	PE20081842A1 (fr)
TN (1)	TN2009000197A1 (fr)
TW (1)	TWI481424B (fr)
WO (1)	WO2008075762A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ577281A (en)	2006-12-18	2011-12-22	Takeda Pharmaceutical	Sustained-release composition and method for producing the same
AR079657A1 (es) *	2009-12-22	2012-02-08	Takeda Pharmaceutical	Formulacion de liberacion sostenida
BR112012032544A2 (pt) *	2010-06-25	2016-10-11	Takeda Pharmaceutical	formulação de liberação prolongada, uso de um composto, e, método para produzir a formulação de liberação prolongada.
US20150087624A1 (en) *	2012-04-24	2015-03-26	Osaka University	Method for producing an aqueous dispersion of drug nanoparticles and use thereof
KR101558083B1 (ko) *	2014-04-07	2015-10-07	에스케이케미칼주식회사	약물함유 고분자미립구 제조방법
WO2015158823A1 (fr)	2014-04-16	2015-10-22	Veyx-Pharma Gmbh	Composition pharmaceutique vétérinaire et utilisation de ladite composition pharmaceutique vétérinaire
WO2016020901A1 (fr)	2014-08-07	2016-02-11	Acerta Pharma B.V.	Procédés de traitement de cancers, maladies immunitaires et auto-immunes, et maladies inflammatoires basés sur l'occupation de btk et le taux de resynthèse de btk
JP2020535224A (ja) *	2017-09-26	2020-12-03	ナノミ・ベー・フェー	二重エマルション技術によるマイクロ粒子を調製する方法
KR101936040B1 (ko)	2018-04-23	2019-01-08	주식회사 씨트리	안정화된 단상 혼합액을 이용하는 생분해성 미립구의 제조방법
EP3785734B1 (fr)	2019-03-26	2023-04-12	Novel Pharma Inc.	Dérivé de gnrh de liaison aux acides gras à action prolongée et composition pharmaceutique contenant celui-ci
CN114126592A (zh) *	2019-07-12	2022-03-01	G2G生物公司	含有利凡斯的明的长效制剂及其制备方法
CN116270491A (zh) *	2023-03-30	2023-06-23	北京博恩特药业有限公司	一种醋酸亮丙瑞林缓释微球及其制备方法

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3297033A (en)	1963-10-31	1967-01-10	American Cyanamid Co	Surgical sutures
US3565869A (en)	1968-12-23	1971-02-23	American Cyanamid Co	Extrudable and stretchable polyglycolic acid and process for preparing same
US3773919A (en)	1969-10-23	1973-11-20	Du Pont	Polylactide-drug mixtures
US3755558A (en)	1971-02-23	1973-08-28	Du Pont	Polylactide drug mixtures for topical application atelet aggregation
US3839297A (en)	1971-11-22	1974-10-01	Ethicon Inc	Use of stannous octoate catalyst in the manufacture of l(-)lactide-glycolide copolymer sutures
US3912692A (en)	1973-05-03	1975-10-14	American Cyanamid Co	Process for polymerizing a substantially pure glycolide composition
US3890283A (en)	1973-06-04	1975-06-17	American Cyanamid Co	Process for post-polymerizing polyglycolic acid
US4258063A (en)	1978-06-23	1981-03-24	Henkel Corporation	Self-emulsifying cosmetic base
US4249531A (en)	1979-07-05	1981-02-10	Alza Corporation	Bioerodible system for delivering drug manufactured from poly(carboxylic acid)
US4273920A (en)	1979-09-12	1981-06-16	Eli Lilly And Company	Polymerization process and product
PH19942A (en)	1980-11-18	1986-08-14	Sintex Inc	Microencapsulation of water soluble polypeptides
US5366734A (en)	1981-02-16	1994-11-22	Zeneca Limited	Continuous release pharmaceutical compositions
IE52535B1 (en) *	1981-02-16	1987-12-09	Ici Plc	Continuous release pharmaceutical compositions
US4479911A (en)	1982-01-28	1984-10-30	Sandoz, Inc.	Process for preparation of microspheres and modification of release rate of core material
US4605730A (en)	1982-10-01	1986-08-12	Ethicon, Inc.	Surgical articles of copolymers of glycolide and ε-caprolactone and methods of producing the same
US4539981A (en)	1982-11-08	1985-09-10	Johnson & Johnson Products, Inc.	Absorbable bone fixation device
FR2537980B1 (fr)	1982-12-17	1986-12-19	Sandoz Sa	Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
CH656884A5 (de)	1983-08-26	1986-07-31	Sandoz Ag	Polyolester, deren herstellung und verwendung.
JPS60100516A (ja)	1983-11-04	1985-06-04	Takeda Chem Ind Ltd	徐放型マイクロカプセルの製造法
CA1256638A (fr)	1984-07-06	1989-06-27	Motoaki Tanaka	Polymere, et sa production
JPH0678425B2 (ja)	1984-07-06	1994-10-05	和光純薬工業株式会社	重合体の新規製造法
ATE61935T1 (de)	1985-02-07	1991-04-15	Takeda Chemical Industries Ltd	Verfahren zur herstellung von mikrokapseln.
JP2551756B2 (ja)	1985-05-07	1996-11-06	武田薬品工業株式会社	ポリオキシカルボン酸エステルおよびその製造法
MY107937A (en)	1990-02-13	1996-06-29	Takeda Chemical Industries Ltd	Prolonged release microcapsules.
JP2653255B2 (ja)	1990-02-13	1997-09-17	武田薬品工業株式会社	長期徐放型マイクロカプセル
FR2658432B1 (fr)	1990-02-22	1994-07-01	Medgenix Group Sa	Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation.
CA2040141C (fr)	1990-04-13	2002-05-14	Minoru Yamada	Polymeres biodegradables a haute densite moleculaire production et utilisation desdits polymeres
JP3116311B2 (ja)	1990-06-13	2000-12-11	エーザイ株式会社	マイクロスフィアの製法
FR2693905B1 (fr)	1992-07-27	1994-09-02	Rhone Merieux	Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
EP0582459B1 (fr)	1992-08-07	1998-01-07	Takeda Chemical Industries, Ltd.	Production de microcapsules de médicaments solubles dans l'eau
JP3277342B2 (ja)	1992-09-02	2002-04-22	武田薬品工業株式会社	徐放性マイクロカプセルの製造法
TW333456B (en)	1992-12-07	1998-06-11	Takeda Pharm Ind Co Ltd	A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
DE4342092B4 (de)	1993-12-09	2007-01-11	Zentaris Gmbh	Langwirkende Injektionssuspension und Verfahren zur Herstellung
DE69508985T2 (de)	1994-02-21	1999-08-19	Takeda Chemical Industries	Polyester Matrix für eine pharmazeutische Zusammensetzung mit verzögerter Freigabe
JP3490171B2 (ja)	1994-02-21	2004-01-26	武田薬品工業株式会社	生体内分解性ポリマーの末端カルボキシル基におけるエステル
JPH07273447A (ja)	1994-03-29	1995-10-20	Sumitomo Kinzoku Ceramics:Kk	セラミック回路基板及びその製造方法
US5763513A (en)	1994-05-19	1998-06-09	Mitsui Toatsu Chemicals, Inc.	L-lactic acid polymer composition, molded product and film
FR2736508B1 (fr)	1995-07-13	1997-09-19	Francais Prod Ind Cfpi	Nouvelle forme solide de stockage et de commercialisation pour compositions phytosanitaires et moyens pour sa preparation
TW448055B (en)	1995-09-04	2001-08-01	Takeda Chemical Industries Ltd	Method of production of sustained-release preparation
CA2192773C (fr)	1995-12-15	2008-09-23	Hiroaki Okada	Obtention d'une preparation a liberation prolongee pour injection
CA2192782C (fr)	1995-12-15	2008-10-14	Nobuyuki Takechi	Production de microsphere
DK0839525T3 (da)	1996-10-31	2004-11-29	Takeda Pharmaceutical	Præparat med forlænget frigivelse
WO1998032423A1 (fr)	1997-01-29	1998-07-30	Takeda Chemical Industries, Ltd.	Microspheres a liberation prolongee, leur production et utilisation
JPH10273447A (ja)	1997-01-29	1998-10-13	Takeda Chem Ind Ltd	徐放性マイクロスフィア、その製造法および用途
US5945126A (en)	1997-02-13	1999-08-31	Oakwood Laboratories L.L.C.	Continuous microsphere process
GB9718986D0 (en)	1997-09-09	1997-11-12	Danbiosyst Uk	Controlled release microsphere delivery system
US5989463A (en)	1997-09-24	1999-11-23	Alkermes Controlled Therapeutics, Inc.	Methods for fabricating polymer-based controlled release devices
NZ505651A (en) *	1998-01-16	2003-08-29	Takeda Chemical Industries Ltd	Sustained release composition comprising biologically active substance, hydroxynaphthoic acid and biodegradable polymer
JPH11269094A (ja)	1998-01-16	1999-10-05	Takeda Chem Ind Ltd	徐放性組成物、その製造法および用途
KR20010086245A (ko)	1998-03-04	2001-09-10	다케다 야쿠힌 고교 가부시키가이샤	Ａⅱ 길항제용 서방성 제제, 그것의 제조 및 용도
US6114495A (en)	1998-04-01	2000-09-05	Cargill Incorporated	Lactic acid residue containing polymer composition and product having improved stability, and method for preparation and use thereof
US6565874B1 (en)	1998-10-28	2003-05-20	Atrix Laboratories	Polymeric delivery formulations of leuprolide with improved efficacy
US6270802B1 (en)	1998-10-28	2001-08-07	Oakwood Laboratories L.L.C.	Method and apparatus for formulating microspheres and microcapsules
DE69923795T2 (de)	1998-12-15	2006-03-16	Takeda Pharmaceutical Co. Ltd.	Verfahren zur Herstellung biologisch-abbaubarer Polyester
IL147417A0 (en)	1999-07-15	2002-08-14	Takeda Chemical Industries Ltd	Sustained release compositions, methods for producing the same and uses thereof
WO2001010414A1 (fr)	1999-08-04	2001-02-15	Oakwood Laboratories L.L.C.	Microspheres presentant une liberation lente
ES2256276T5 (es)	2000-08-07	2011-02-22	Wako Pure Chemical Industries, Ltd.	Polímero de ácido láctico y procedimiento para su producción.
US6824822B2 (en)	2001-08-31	2004-11-30	Alkermes Controlled Therapeutics Inc. Ii	Residual solvent extraction method and microparticles produced thereby
WO2002043766A1 (fr)	2000-11-29	2002-06-06	Takeda Chemical Industries, Ltd.	Compositions medicinales et leur procede de preparation
AU2002221139A1 (en)	2000-12-15	2002-06-24	Takeda Chemical Industries Ltd.	Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof
AR034641A1 (es)	2001-06-29	2004-03-03	Takeda Pharmaceutical	Composicion de liberacion controlada y metodo para producirla
TWI225416B (en)	2001-06-29	2004-12-21	Takeda Chemical Industries Ltd	Sustained-release composition and process for producing the same
US20050064039A1 (en)	2001-12-26	2005-03-24	Tomomichi Futo	Novel microsphere and method for production thereof
CN1662260B (zh) *	2002-06-25	2010-04-28	武田药品工业株式会社	缓释组合物的制备方法
US6803708B2 (en) *	2002-08-22	2004-10-12	Cdream Display Corporation	Barrier metal layer for a carbon nanotube flat panel display
CA2915574C (fr) *	2003-07-18	2017-02-07	Oakwood Laboratories, L.L.C.	Methode pour empecher la perte de poids moleculaire des polymeres, la formation d'impuretes et la gelification dans les composes polymeriques
US8900636B2 (en)	2003-07-23	2014-12-02	Evonik Corporation	Controlled release compositions
EP1670824A2 (fr) *	2003-09-24	2006-06-21	Montana State University	Anticorps monoclonaux de norovirus et peptides
TW200613012A (en)	2004-07-02	2006-05-01	Takeda Pharmaceuticals Co	Sustained-release composition, process for producing the same and use of the same
US7906136B2 (en)	2004-10-01	2011-03-15	Ramscor, Inc.	Conveniently implantable sustained release drug compositions
CA2586846C (fr)	2004-11-10	2013-12-31	Qlt Usa Inc.	Systeme d'administration polymere stabilise
NZ577281A (en)	2006-12-18	2011-12-22	Takeda Pharmaceutical	Sustained-release composition and method for producing the same

2007
- 2007-12-17 NZ NZ577281A patent/NZ577281A/en unknown
- 2007-12-17 BR BRPI0720582-1A patent/BRPI0720582B1/pt active IP Right Grant
- 2007-12-17 AU AU2007335406A patent/AU2007335406B2/en active Active
- 2007-12-17 MY MYPI20092544A patent/MY148370A/en unknown
- 2007-12-17 KR KR1020097011993A patent/KR101522035B1/ko active Active
- 2007-12-17 EP EP07859925.5A patent/EP2094246B1/fr active Active
- 2007-12-17 CA CA2671670A patent/CA2671670C/fr not_active Expired - Fee Related
- 2007-12-17 ES ES07859925T patent/ES2791698T3/es active Active
- 2007-12-17 US US12/312,751 patent/US8921326B2/en active Active
- 2007-12-17 CL CL200703658A patent/CL2007003658A1/es unknown
- 2007-12-17 NO NO20092662A patent/NO347209B1/no unknown
- 2007-12-17 TW TW096148177A patent/TWI481424B/zh active
- 2007-12-17 AR ARP070105656A patent/AR064381A1/es not_active Application Discontinuation
- 2007-12-17 WO PCT/JP2007/074617 patent/WO2008075762A1/fr active Application Filing
- 2007-12-17 JP JP2009524632A patent/JP4564098B2/ja active Active
- 2007-12-17 GE GEAP200711311A patent/GEP20125597B/en unknown
- 2007-12-17 CN CN2007800469578A patent/CN101563068B/zh active Active
- 2007-12-17 EA EA200970600A patent/EA016176B1/ru not_active IP Right Cessation
- 2007-12-17 MX MX2009006653A patent/MX2009006653A/es active IP Right Grant
2008
- 2008-01-02 PE PE2008000035A patent/PE20081842A1/es active IP Right Grant
2009
- 2009-05-20 IL IL198845A patent/IL198845A/en active IP Right Grant
- 2009-05-20 TN TNP2009000197A patent/TN2009000197A1/fr unknown
- 2009-06-12 CR CR10867A patent/CR10867A/es unknown
- 2009-06-17 MA MA32010A patent/MA31006B1/fr unknown
- 2009-06-17 EC EC2009009439A patent/ECSP099439A/es unknown
- 2009-06-17 DO DO2009000144A patent/DOP2009000144A/es unknown
- 2009-06-18 CO CO09063558A patent/CO6180498A2/es not_active Application Discontinuation
2010
- 2010-06-07 JP JP2010130277A patent/JP5258844B2/ja active Active
2014
- 2014-11-19 US US14/547,467 patent/US9617303B2/en active Active
2017
- 2017-02-28 US US15/444,712 patent/US9713595B2/en active Active

Also Published As

Publication number	Publication date
TW200833376A (en)	2008-08-16
MA31006B1 (fr)	2009-12-01
KR101522035B1 (ko)	2015-05-20
EP2094246A1 (fr)	2009-09-02
US8921326B2 (en)	2014-12-30
NO20092662L (no)	2009-09-07
AU2007335406A1 (en)	2008-06-26
CA2671670A1 (fr)	2008-06-26
US9617303B2 (en)	2017-04-11
CN101563068B (zh)	2013-03-20
EA200970600A1 (ru)	2009-12-30
JP2010222371A (ja)	2010-10-07
GEP20125597B (en)	2012-08-10
JP5258844B2 (ja)	2013-08-07
NZ577281A (en)	2011-12-22
CR10867A (es)	2009-07-30
CO6180498A2 (es)	2010-07-19
CA2671670C (fr)	2015-02-10
PE20081842A1 (es)	2009-01-19
MY148370A (en)	2013-04-15
US20150080322A1 (en)	2015-03-19
KR20090094272A (ko)	2009-09-04
EP2094246B1 (fr)	2020-04-01
AR064381A1 (es)	2009-04-01
CL2007003658A1 (es)	2008-05-09
BRPI0720582A2 (pt)	2014-02-04
ES2791698T3 (es)	2020-11-05
DOP2009000144A (es)	2009-07-30
US20170165204A1 (en)	2017-06-15
IL198845A0 (en)	2010-02-17
AU2007335406B2 (en)	2012-09-13
EA016176B1 (ru)	2012-02-28
MX2009006653A (es)	2009-07-02
US9713595B2 (en)	2017-07-25
JP2010513225A (ja)	2010-04-30
CN101563068A (zh)	2009-10-21
IL198845A (en)	2015-07-30
TWI481424B (zh)	2015-04-21
US20110135741A1 (en)	2011-06-09
JP4564098B2 (ja)	2010-10-20
WO2008075762A1 (fr)	2008-06-26
ECSP099439A (es)	2009-07-31
NO347209B1 (no)	2023-07-03
BRPI0720582B1 (pt)	2021-08-24

Publication	Publication Date	Title
MY148370A (en)	2013-04-15	Sustained-release composition and method for producing the same
US20190358332A1 (en)	2019-11-28	Oral product with alginate composition of releasable substance
EP1786400A4 (fr)	2008-07-09	Compositions pharmaceutiques permettant la liberation progressive de composes bioactifs
MXPA05012791A (es)	2006-02-22	Formulacion sostenida que contiene dimeticona.
TW200608975A (en)	2006-03-16	Pharmaceutical compositions
MY127797A (en)	2006-12-29	3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol-containing pharmaceutical composition with slow release of active indgredient
MY151468A (en)	2014-05-30	Controlled release solid preparation
WO2008157614A3 (fr)	2009-02-05	Administration soutenue de médicament à partir de microparticules polymères biodégradables
RU2004111596A (ru)	2005-04-20	Офтальмические композиции в форме депо для периокулярного или субконъюнктивального введения
CA2468703A1 (fr)	2003-06-05	Compositions polymeres a liberation controlee de composes stimulant la formation osseuse
WO2008071407A3 (fr)	2009-02-26	Pilules enrobées
ATE322513T1 (de)	2006-04-15	Milchsäurepolymer und verfahren zu dessen herstellung
MY139606A (en)	2009-10-30	Sustained-release composition and process for producing the same
UA97396C2 (ru)	2012-02-10	Фармацевтическая композиция пролонгированного высвобождения, содержащая пасиреотид памоат в микрочастицах
MX2009012856A (es)	2009-12-15	Composicion farmaceutica de liberacion lenta hecha de microparticulas.
RU2007143556A (ru)	2009-06-10	Композиции с пролонгированным высвобождением
WO2004078111A3 (fr)	2004-10-28	Compositions de minocycline a liberation prolongee et leurs procedes de preparation
WO2006053089A3 (fr)	2006-08-24	Methodes et formulations permettant de preparer des compositions pharmaceutiques contenant du bupropion
UA97125C2 (ru)	2012-01-10	Композиция продолжительного высвобождения и способ ее получения
WO2007015270A3 (fr)	2007-04-19	Nouvelles compositions a liberation controlee a base d'inhibiteurs selectifs de la recapture de la serotonine
BRPI0606373A2 (pt)	2009-06-23	composição de xarope compreendendo dexibuprofeno como ingrediente ativo e método para a preparação da mesma
RU2011108370A (ru)	2012-09-20	Жевательная композиция, включающая альгинат, бикарбонат и карбонат
Tarawneh et al.	2019	Development and characterization of k-carrageenan platforms as periodontal intra-pocket films
NZ596275A (en)	2014-01-31	Burst drug release compositions
WO2002017877A3 (fr)	2002-08-08	Compositions pour granules pharmaceutiques a liberation controlee destinees a limiter les effets secondaires de medicaments